# A Diabetes Study to Treat A Population Previously Not at Target

> **NCT00747149** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 598 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00747149
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 598 (ACTUAL)
- **Last updated:** 2011-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00747149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00747149, "A Diabetes Study to Treat A Population Previously Not at Target". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00747149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*